Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Sara Pernikoff Clear advanced filters
  • A range of humoral related adverse events can occur after treatment of haematological malignancy with chimeric antigen receptor cell therapies. Here the authors characterise the persistence of humoral immunity and response to vaccination after patients receive B cell targeted chimeric antigen receptor T cell therapy.

    • Stosh Ozog
    • Elizabeth M. Krantz
    • Joshua A. Hill
    ResearchOpen Access
    Nature Communications
    P: 1-17
  • Human metapneumovirus can cause severe lung disease in vulnerable people, yet no vaccines or treatments are available. Harris et al. identify 4F11, a potent monoclonal antibody with unique binding properties, and demonstrate its efficacy in reducing viral loads in vitro and in vivo.

    • Evelyn D. Harris
    • Morgan McGovern
    • Jim Boonyaratanakornkit
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-16